Transcriptomic and Immunohistochemical Analysis of Progressive Keratoconus Reveal Altered WNT10A in Epithelium and Bowman's Layer.
Adult
Blotting, Western
Bowman Membrane
/ metabolism
Collagen Type I
/ genetics
Collagen Type I, alpha 1 Chain
Epithelium, Corneal
/ metabolism
Female
Gene Expression Regulation
/ physiology
Humans
Immunohistochemistry
Keratoconus
/ diagnosis
Male
Phenotype
Plasmids
/ genetics
RNA, Messenger
/ genetics
Real-Time Polymerase Chain Reaction
Sequence Analysis, RNA
Transcriptome
Wnt Proteins
/ genetics
Young Adult
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
03 05 2021
03 05 2021
Historique:
entrez:
14
5
2021
pubmed:
15
5
2021
medline:
2
10
2021
Statut:
ppublish
Résumé
To identify global gene expression changes in the corneal epithelium of keratoconus (KC) patients compared to non-KC myopic controls. RNA-sequencing was performed on corneal epithelium samples of five progressive KC and five myopic control patients. Selected results were validated using TaqMan quantitative PCR (qPCR) on 31 additional independent samples, and protein level validation was conducted using western blot analysis on a subset. Immunohistochemistry was performed on tissue microarrays containing cores from over 100 KC and control cases. WNT10A transcript levels in corneal epithelium were correlated with tomographic indicators of KC disease severity in 15 eyes. Additionally, WNT10A was overexpressed in vitro in immortalized corneal epithelial cells. WNT10A was found to be underexpressed in KC epithelium at the transcript (ratio KC/control = 0.59, P = 0.02 per RNA-sequencing study; ratio = 0.66, P = 0.03 per qPCR) and protein (ratio = 0.07, P = 0.06) levels. Immunohistochemical analysis also indicated WNT10A protein was decreased in Bowman's layer of KC patients. In contrast, WNT10A transcript level positively correlated with increased keratometry (Kmax ρ = 0.57, P = 0.02). Finally, WNT10A positively regulated COL1A1 expression in corneal epithelial cells. A specific Wnt ligand, WNT10A, is reduced at the mRNA and protein level in KC epithelium and Bowman's layer. This ligand positively regulates collagen type I expression in corneal epithelial cells. The results suggest that WNT10A expression in the corneal epithelium may play a role in progressive KC.
Identifiants
pubmed: 33988693
pii: 2772600
doi: 10.1167/iovs.62.6.16
pmc: PMC8132000
doi:
Substances chimiques
Collagen Type I
0
Collagen Type I, alpha 1 Chain
0
RNA, Messenger
0
WNT10A protein, human
0
Wnt Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Subventions
Organisme : NEI NIH HHS
ID : K08 EY027474
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001765
Pays : United States
Références
Invest Ophthalmol Vis Sci. 2012 Feb 23;53(2):927-35
pubmed: 22247476
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1501-1509
pubmed: 30994860
Sci Rep. 2020 Dec 7;10(1):21382
pubmed: 33288782
Biochim Biophys Acta. 2014 Jan;1845(1):53-65
pubmed: 24316024
Am J Ophthalmol. 2017 Mar;175:169-172
pubmed: 28039037
J Cataract Refract Surg. 2018 Jan;44(1):71-77
pubmed: 29502621
EuPA Open Proteom. 2015 Nov 02;10:9-18
pubmed: 29900094
Ocul Surf. 2015 Oct;13(4):272-83
pubmed: 26235733
Exp Eye Res. 2011 Apr;92(4):282-98
pubmed: 21281627
Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319
pubmed: 9493273
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Proteomics. 2013 Jul 11;87:122-31
pubmed: 23727491
Invest Ophthalmol Vis Sci. 1988 May;29(5):727-36
pubmed: 3366564
Hum Mol Genet. 2015 Sep 1;24(17):5060-8
pubmed: 26049155
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):15
pubmed: 32396634
Mol Vis. 2006 Dec 20;12:1615-25
pubmed: 17200661
Nat Commun. 2017 Jun 07;8:15397
pubmed: 28589954
J Endod. 2014 Oct;40(10):1593-9
pubmed: 25134734
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2717-2728
pubmed: 29860458
Pathology. 2012 Apr;44(3):234-9
pubmed: 22406479
Ophthalmology. 2015 May;122(5):909-17
pubmed: 25596620
Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6181-91
pubmed: 21676910
Exp Eye Res. 2006 Feb;82(2):201-9
pubmed: 16083875
Invest Ophthalmol Vis Sci. 2011 Jul 01;52(7):4734-41
pubmed: 21357396
Graefes Arch Clin Exp Ophthalmol. 1991;229(2):157-63
pubmed: 2044978
Sci Rep. 2020 Jun 18;10(1):9907
pubmed: 32555404
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1498-505
pubmed: 26903625
PLoS One. 2013 Jun 18;8(6):e66770
pubmed: 23825088
Curr Opin Ophthalmol. 1995 Aug;6(4):44-56
pubmed: 10150882
Hum Mol Genet. 2016 Nov 15;25(22):5035-5045
pubmed: 28171582
Cornea. 2006 Apr;25(3):296-305
pubmed: 16633030
Proc Natl Acad Sci U S A. 1977 Jan;74(1):39-43
pubmed: 264692
Transl Vis Sci Technol. 2019 Jul 26;8(4):10
pubmed: 31372311
J Biol Chem. 1994 Oct 7;269(40):24959-66
pubmed: 7929179
Nat Rev Mol Cell Biol. 2017 Jun;18(6):375-388
pubmed: 28293032
Clin Exp Ophthalmol. 2010 Jan;38(1):43-8
pubmed: 20447100
Differentiation. 2012 Sep;84(2):203-13
pubmed: 22784633
PLoS One. 2018 Mar 29;13(3):e0195156
pubmed: 29596490
Hum Mol Genet. 2020 Nov 4;29(18):3154-3164
pubmed: 32716492
Cornea. 2020 Aug;39(8):946-951
pubmed: 32355111
Eur J Hum Genet. 2017 May;25(5):582-590
pubmed: 28145428
PeerJ. 2020 Aug 20;8:e9793
pubmed: 32879808
Cornea. 2014 Jan;33(1):49-55
pubmed: 24270675
Sci Rep. 2018 Jan 10;8(1):389
pubmed: 29321650
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):470-8
pubmed: 15671271
Micron. 2012 Dec;43(12):1293-8
pubmed: 22421334
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Invest Ophthalmol Vis Sci. 1981 Jun;20(6):738-50
pubmed: 7016805
Curr Eye Res. 2018 Apr;43(4):455-459
pubmed: 29381095
Arch Ophthalmol. 1998 Jan;116(1):62-8
pubmed: 9445209
Mol Vis. 2013;19:509-xxx
pubmed: 23441124
J Clin Oncol. 2003 Oct 15;21(20):3798-807
pubmed: 12953099
Mol Cell Biol. 2002 Feb;22(4):1172-83
pubmed: 11809808